Red Queen Therapeutics

Red Queen Therapeutics develops biotechnological drugs aimed at providing a rapid response to existing and emerging pathogens that threaten human health and life. The company operates a novel plug-and-play antiviral platform based on stapled peptide decoys, which can be quickly deployed against pandemic and potentially pandemic viruses, as well as other viruses causing recurrent or untreated diseases, helping users protect themselves from viruses and infections entering the body.